[Therapy of Inflammatory Bowel Disease]

Area of Science:

• Gastroenterology
• Immunology

Context:

• Rising incidence of Inflammatory Bowel Disease (IBD), encompassing Crohn's Disease and Ulcerative Colitis, observed in Switzerland.
• IBD management requires a shift from symptom relief to disease activity control, aiming for mucosal healing and deep remission.

Purpose:

• To outline current therapeutic strategies for IBD, emphasizing early and individualized treatment approaches.
• To highlight the importance of prompt therapy intensification for patients with unfavorable predictive parameters in IBD.

Summary:

• Effective IBD treatment involves early, personalized medical therapy to prevent gastrointestinal damage and surgical interventions.
• Utilizing established immunosuppressive agents through "early step-up" or "top-down" approaches is crucial for managing IBD.
• Updated guidelines address key medical questions, but clinical expertise remains vital for sustained IBD patient care.

Impact:

• Facilitates better patient outcomes by preventing long-term complications associated with IBD.
• Informs healthcare providers on optimizing IBD treatment protocols for improved remission rates.
• Supports the development of specialized care pathways for complex IBD cases.